Alveo Technologies

16 articles about Alveo Technologies

• Alveo Technologies and Corteva Agriscience Collaborate to Advance Molecular Crop Disease Diagnostics and Improve Crop Yields

  10/24/2023

  Alveo Technologies, Inc. announced a collaboration with Corteva Agriscience to expand the offering of its novel eco-friendly molecular sensing and disease diagnostics technology to include a first-in-field agricultural disease diagnostic.

• Alveo Technologies Announces Partner Program and Portal, New Enablement Software Suite, Further Empowering Partners in Co-Development of Advanced Molecular Diagnostics

  7/11/2023

  Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary be.well™ technology platform, launched a web-based partner portal and suite of enablement software tools to further drive innovative partnerships onto the platform to co-develop and commercialize rapid, point of need diagnostic solutions across multiple life sciences industry sectors.

• Alveo Technologies Announces ISO 13485:2016 Certification

  3/21/2023

  Alveo Technologies, Inc. today announced its quality management system (QMS) has achieved ISO 13485:2016 certification for the design, development and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease.

• Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets

  1/5/2023

  Alveo Technologies, Inc. announced it has signed a Memorandum of Understanding with the Barbados Investment and Development Corporation to co-develop on its novel molecular sensing platform, while contributing to the growth of the life sciences industry in the Caribbean nation.

• Alveo Technologies Announces New Executive Leadership, Open Platform Strategy

  11/17/2022

  Alveo Technologies, Inc. announced the appointment of three life sciences industry leaders to its senior executive team to advance the development of its novel molecular sensing and diagnostics technology and lead the company through strategic growth and commercialization of its rapid, multiplexed molecular diagnostic platform, be.well™.

• Alveo Technologies Appoints Veteran Biotech and Diagnostics Leader to Board of Directors

  5/13/2021

  Alveo Technologies , Inc., an infectious disease testing leader, announced today biotechnology, diagnostics and medical device executive Neil Gunn has accepted an appointment to its board of directors

• Alveo Technologies' be.well COVID-19 Test Wins XPRIZE Rapid Covid Testing Competition

  3/17/2021

  Prestigious honor validates potential of Alveo's low-cost, accessible COVID-19 testing technology as company prepares for commercialization

• Alveo Technologies Announces CE Mark for Its be.well COVID-19 Flex Test

  2/10/2021

  Alveo Technologies, Inc. (Alveo) announced today that it has received its first regulatory approval with the CE (Conformité Européenne) Mark for its be.well™ COVID-19 Flex Test.

• 

  BioSpace Movers & Shakers, Sept. 18

  9/18/2020

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

• Alveo Technologies Expands Scientific Advisory Board with Appointment of Esteemed Healthcare Business Executive, Fran Soistman

  9/15/2020

  Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced that Fran Soistman has joined the company’s Scientific Advisory Board (SAB)

• 

  BioSpace Movers & Shakers, Aug. 21

  8/21/2020

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
• 

  BioSpace Movers & Shakers, July 10

  7/10/2020

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
• 

  Biopharma Update on the Novel Coronavirus: May 1

  5/1/2020

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 1, 2020.

• Alveo Technologies Announces Research Collaboration with Janssen Pharmaceuticals, Inc. to Advance At-Home Testing Platform for Viral Infectious Diseases

  4/30/2020

  Alveo Technologies , a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, announced today that it has entered into a research collaboration with Janssen Pharmaceuticals, Inc., (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to advance Alveo’s be.well™ platform of analyzers, nasal swabs and cartridges for the dete

• Alveo Announces Appointments of CTO and Director of Assay Development

  7/12/2018

  Alveo Technologies, Inc. has been named Chief Technology Officer and Rixun Fang, Ph.D., has been appointed Director of Assay Development.

• 

  Bay Area's Alveo Lands $38M to Create Accessible Diagnostics Devices

  1/8/2018

  The offering proceeds will be used to advance the optimization and commercialization of Alveo's rapid diagnostic platform for infectious diseases.